SARCLISA

Brand Description

SARCLISA is an FDA-approved therapy for treating multiple myeloma, specifically indicated for patients who are newly diagnosed or have relapsed, utilizing isatuximab-irfc in combination with other treatments.

Associated Domains

Screenshot of www.sarclisahcp.com
www.sarclisahcp.com

IAB Categories:

Health & Fitness

IAB Ad Products:

Medical and BiotechnologyHealth and Medical ServicesPharmaceuticals
IDDomainSeatBidTimestampStatusAd FormatSub FormatSizeQuality ScoreData TransferredComputational Cost